Safety, efficacy, and cardiovascular benefits of combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists in patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials Review (Faculty180)

cited authors

  • Mousavi, A; Shojaei, S; Soleimani, H; Semirani-Nezhad, D; Ebrahimi, P; Zafari, A; Ebrahimi, R; Roozbehi, K; Harrison, A; Syed, M A; Kuno, T; Askari, M K; Almandoz, J P; Jun, J H; Hosseini, K

authors